Junki Mizusawa
Papers
3
Total Citations
44
H-Index
2
About
Junki Mizusawa is a leading surgical oncologist whose work is redefining the standards of care for gastrointestinal cancers through rigorous clinical trials. His primary research focuses on the comparative effectiveness of minimally invasive surgical techniques—specifically robotic and laparoscopic approaches—for gastric and pancreatic cancers. Mizusawa is the principal investigator of the landmark JCOG1907 (MONA LISA) study, a phase III trial investigating whether robot-assisted gastrectomy offers superior outcomes over laparoscopic gastrectomy for gastric cancer patients, addressing critical drawbacks like motion restriction and spatial perception. His impact is further underscored by his leadership of the JCOG2202 (LAPAN) study, a multi-institutional randomized trial comparing minimally invasive distal pancreatectomy to open surgery for pancreatic cancer, a project that tackles the pressing question of oncologic safety. Additionally, his phase II trial (JCOG1809) evaluates the safety of laparoscopic/robotic total gastrectomy with spleen-preserving dissection for proximal gastric cancer, aiming to reduce severe complications. With his work cited in high-impact protocols and shaping future surgical guidelines, Mizusawa is a pivotal figure advancing evidence-based, patient-centered innovation in oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3